Zofran Use Linked to Various Birth Defects

Zofran is an anti-nausea drug used to help cancer patients receiving chemotherapy treatment as well as people who become nauseous after surgery. The FDA has cleared Zofran use as a safe treatment for these conditions, but not for a effective way to treat morning sickness. Sadly, although the FDA has placed Zofran in category B for pregnancy use, the makers of the drug have ignored such warnings, and now families are seeing devastating results.

GlaxoSmithKline (GSK) is the makers of Zofran, and heavily marketed and even pushed Zofran use for the use during pregnancy for morning sickness. As a result, mothers that took Zofran during the first trimester of pregnancy are having babies with the following birth defects: cleft lip, cleft palate, and heart defects. Tragically, GSK knew that Zofran reached past the placental barrier when it was tested on animals, and continued to market the drug as safe despite the warnings of research and the FDA. Now, many families are filing Zofran lawsuits against the makers for negligence and failure to warn.

If your child has suffered as a result of Zofran, the skilled St. Louis personal injury attorneys at Meyerkord & Kurth can help. Please contact us today for a free consultation.